Evidence map›Paper›PMID 28594169›Full record

ArticleJournal of natural products2017

Biosynthesis of Fluorinated Peptaibols Using a Site-Directed Building Block Incorporation Approach.

José Rivera-Chávez, Huzefa A Raja, Tyler N Graf, Joanna E Burdette, Cedric J Pearce, Nicholas H Oberlies

Open access · greenAbstract read
In one paragraph

Article in Journal of natural products, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Enzymatic synthesis of fluorinated compounds.Applied microbiology and biotechnology · 2021
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

José Rivera-ChávezDepartment of Chemistry and Biochemistry, University of North Carolina at Greensboro , P.O. Box 26170, Greensboro, North Carolina 27412, United States.
Huzefa A RajaDepartment of Chemistry and Biochemistry, University of North Carolina at Greensboro , P.O. Box 26170, Greensboro, North Carolina 27412, United States.
Tyler N GrafDepartment of Chemistry and Biochemistry, University of North Carolina at Greensboro , P.O. Box 26170, Greensboro, North Carolina 27412, United States.
Joanna E BurdetteDepartment of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago , Chicago, Illinois 60612, United States.
Cedric J PearceMycosynthetix, Inc., 505 Meadowlands Drive, Suite 103, Hillsborough, North Carolina 27278, United States.
Nicholas H OberliesDepartment of Chemistry and Biochemistry, University of North Carolina at Greensboro , P.O. Box 26170, Greensboro, North Carolina 27412, United States.ORCID 0000-0002-0354-8464
University of North Carolina at Greensboro · USMycosynthetix (United States) · USUniversity of Illinois Chicago · US

Funding

Project 3:Isolation Chemistry of Filamentous Fungi and Biological EvaluationP01CA125066 · NCI · OHIO STATE UNIVERSITY · PI JIMMY ORJALA · 2007 to 2026
$27.2M
NCI NIH HHS P01 CA125066
6 · The paper itself

Abstract

Synthetic biological approaches, such as site-directed biosynthesis, have contributed to the expansion of the chemical space of natural products, making possible the biosynthesis of unnatural metabolites that otherwise would be difficult to access. Such methods may allow the incorporation of fluorine, an atom rarely found in nature, into complex secondary metabolites. Organofluorine compounds and secondary metabolites have both played pivotal roles in the development of drugs; however, their discovery and development are often via nonintersecting tracks. In this context, we used the biosynthetic machinery of Trichoderma arundinaceum (strain MSX70741) to incorporate a fluorine atom into peptaibol-type molecules in a site-selective manner. Thus, fermentation of strain MSX70741 in media containing ortho- and meta-F-phenylalanine resulted in the biosynthesis of two new fluorine-containing alamethicin F50 derivatives. The fluorinated products were characterized using spectroscopic (1D and 2D NMR, including

Indexed as

Amino Acid SequenceAnti-Bacterial AgentsBiological ProductsHumansHydrocarbons, FluorinatedMolecular StructureNuclear Magnetic Resonance, BiomolecularPeptaibolsTrichodermaAnti-Bacterial AgentsBiological ProductsHydrocarbons, FluorinatedPeptaibols

Identifiers

PMID28594169
PMCPMC5485375
OpenAlexW2622068805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.